Oncobiologics
Why Robinhood?
You can watch Oncobiologics and buy or sell other stocks, ETFs, and their options commission-free!About ONS
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF.
ONS Key Statistics
Stock Snapshot
Oncobiologics(ONS) stock is priced at $0.79, giving the company a market capitalization of 31.66M. It carries a P/E multiple of -0.24.
During the trading day, Oncobiologics(ONS) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 5.68M.
Over the past 52 weeks, Oncobiologics(ONS) stock has traded between a high of $3.39 and a low of $0.16.
Over the past 52 weeks, Oncobiologics(ONS) stock has traded between a high of $3.39 and a low of $0.16.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.